For the year ended 31 December 2025, Verici Dx Plc reported unaudited revenues of $3.8m, driven by first recognised Tutivia™ revenues, increased test volumes, and expanded US reimbursement coverage...
Tern Plc notes that Device Authority, in which it holds a 25.3% stake, has announced further progress in the automotive sector, securing a new OEM customer and expanding an existing Tier 1 deployment...
Verici Dx Plc has entered into an agreement with Blue Cross and Blue Shield of Illinois to provide in-network coverage for Tutivia™, its post-kidney transplant diagnostic test...
CEO Tony Brewer highlights Likewise Group’s sustained revenue growth despite market headwinds, supported by shareholder backing, supplier partnerships, and expanding UK infrastructure...
Gervais Williams highlights the benefits of long-dated, inflation-linked leases, fixed-rate debt, and synergies from the Assura acquisition, which he believes support resilient earnings, dividend growth, and balance sheet strength despite higher interest rates...
Watches of Switzerland Group PLC delivered strong Q3 FY26 performance, with sales growth ahead of expectations across both the US and UK and particularly robust Holiday trading...
Oxford Biomedica has signed a new Commercial Supply Agreement with Bristol Myers Squibb for the manufacture and supply of lentiviral vectors for CAR-T programmes...
For the year ended 31 December 2025, Verici Dx Plc reported unaudited revenues of $3.8m, driven by first recognised Tutivia™ revenues, increased test volumes, and expanded US reimbursement coverage...
Tern Plc notes that Device Authority, in which it holds a 25.3% stake, has announced further progress in the automotive sector, securing a new OEM customer and expanding an existing Tier 1 deployment...
Verici Dx Plc has entered into an agreement with Blue Cross and Blue Shield of Illinois to provide in-network coverage for Tutivia™, its post-kidney transplant diagnostic test...
CEO Tony Brewer highlights Likewise Group’s sustained revenue growth despite market headwinds, supported by shareholder backing, supplier partnerships, and expanding UK infrastructure...
Gervais Williams highlights the benefits of long-dated, inflation-linked leases, fixed-rate debt, and synergies from the Assura acquisition, which he believes support resilient earnings, dividend growth, and balance sheet strength despite higher interest rates...
Watches of Switzerland Group PLC delivered strong Q3 FY26 performance, with sales growth ahead of expectations across both the US and UK and particularly robust Holiday trading...
Oxford Biomedica has signed a new Commercial Supply Agreement with Bristol Myers Squibb for the manufacture and supply of lentiviral vectors for CAR-T programmes...
